CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1061 - 1070 of 1136
Study Number Lead Group Study Title CIRB Study Status
MDA20-02-01 CP-CTNet_CLO-MD Anderson Time Restricted Eating And Metformin (TEAM) in Invasive Breast Cancer (IBC) or Ductal Carcinoma in Situ (DCIS). A randomized, Phase IIb, Window of Opportunity Presurgical Trial. Cancer Prevention and Control CIRB Available to Open
MDA2016-07-02 CP-CTNet_CLO-MD Anderson A Randomized, Double-blind, Placebo-controlled Study of 4-hydroxytamoxifen Topical Gel in Women with Mammographically Dense Breast Cancer Prevention and Control CIRB Available to Open
MDA2017-09-03 CP-CTNet_CLO-MD Anderson Pilot Study of Denosumab in BRCA1/2 Mutation Carriers scheduled for Risk-reducing Salpingooophorectomy Cancer Prevention and Control CIRB Completed
MDA21-06-01 CP-CTNet_CLO-MD Anderson A Phase Ib/II Clinical Trial of Nous-209 for Recurrent Neoantigen Immunogenicity and Cancer Immune Interception in Lynch Syndrome Cancer Prevention and Control CIRB Available to Open
MDA2014-04-01 CP-CTNet_CLO-MD Anderson Alternative Dosing of Exemestane in Postmenopausal Women with Stage 0-II ER-Positive Breast Cancer: a Randomized Presurgical Trial Cancer Prevention and Control CIRB Completed
MDA2014-04-02 CP-CTNet_CLO-MD Anderson VADIS Trial: Phase II trial of Nelipepimut-S Peptide Vaccine in Women with DCIS of the Breast Cancer Prevention and Control CIRB Completed
MDA2013-02-02 CP-CTNet_CLO-MD Anderson Effect of Aspirin on Biomarkers of Barrett’s Esophagus After Successful Eradication of Barrett’s Esophagus with Radiofrequency Ablation Cancer Prevention and Control CIRB Completed
MDA2016-08-02 CP-CTNet_CLO-MD Anderson A Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer Cancer Prevention and Control CIRB Completed
MDA20-01-01 CP-CTNet_CLO-MD Anderson A Phase IIa, Placebo-Controlled, Randomized Study of Daily Obeticholic Acid (OCA) to Reduce Intestinal Polyp Burden in Familial Adenomatous Polyposis (FAP) Cancer Prevention and Control CIRB Available to Open
NWU2017-09-01 CLO-Northwestern University Phase I trial of endoxifen gel versus placebo gel in women undergoing breast surgery Cancer Prevention and Control CIRB Available to Open
Displaying 1061 - 1070 of 1136